Results: Is the Sigma Healthcare share price in the buy zone?

The Sigma Healthcare Ltd (ASX:SIG) share price could be on the rise on Thursday after its full year result came in ahead of its guidance. Should you invest?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sigma Healthcare Ltd (ASX: SIG) share price will be on watch on Thursday following the release of the embattled pharmacy chain operator and distributor's full year results.

Here's how Sigma performed in FY 2019 compared to the prior corresponding period:

  • Revenue down 2.9% to $3.98 billion.
  • Underlying EBITDA down 9.2% to $90.5 million.
  • Underlying net profit after tax down 22.7% to $46.3 million.
  • Reported net profit after tax down 37% to $37 million.
  • Underlying earnings per share of 4.8 cents.
  • Final dividend of 2 cents per share, bringing its total dividend to 3.5 cents per share.

Although this was a very disappointing 12 months for Sigma, the market may respond positively to this result as it has come in higher than its guidance.

The company's underlying EBIT result, which excludes restructuring and due diligence costs, came in at $76.2 million. This was 1.6% higher than its underlying EBIT guidance of $75 million provided to the market in September.

In addition to this, excluding Hepatitis C sales, the company's sales would have been 2.9% higher year on year to $3.75 billion. This was driven by growth in Sigma Hospitals and MPS medication management services businesses. Sales of the low margin Hepatitis C medicines fell $226 million or 50% during the 12 months.

Looking ahead, the company's business transformation program is underway following the completion of the initial diagnostic review by Accenture which identified over $100 million in efficiency gains over the next two years.

Management advised that this is a significant program of work that will also rebase Sigma's operations to a more efficient cost base with greater capacity for growth following the end of the contract with MyChemist/Chemist Warehouse in June 2019.

Sigma's CEO and managing director, Mark Hooper, appears optimistic on the company's future thanks to the business transformation program.

He said: "The recent events have provided the catalyst for us to undertake a detailed review of our operations to ensure we have a sustainable business operating efficiently, but importantly one that adopts a growth mindset to capture the emerging opportunities we see for the business."

Before adding: "We are confident with our ability to execute our strategy to deliver these savings. This work has already commenced with plans and timeframes communicated to our DC team members in March."

Outlook.

Sigma confirmed its EBITDA guidance of $55 million to $60 million for FY 2020. This will be a 34% to 39% decline on FY 2019's underlying EBITDA result.

Should you invest?

Although I would have preferred to see the company merge with rival Australian Pharmaceutical Industries Ltd (ASX: API), if Sigma can deliver the $100 million of efficiency gains over the next two years then it could prove to be a great investment at the current level.

However, I intend to stay clear of its shares until these efficiency gains start to show up in its results.

Until then, I would sooner buy healthcare shares such as CSL Limited (ASX: CSL) or ResMed Inc. (ASX: RMD) instead.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A businessman stacks building blocks.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares hit a new record high today.

Read more »

A man sees some good news on his phone and gives a little cheer.
Share Gainers

Why Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher

These shares are having a better day than most on Thursday. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 29Metals, CAR Group, DroneShield, and Santana Minerals shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.
Broker Notes

Macquarie tips 50% upside for this ASX 200 miner, and it's not BHP!

Unheralded miner poised to surge?

Read more »

A woman sits at a table with notebook on lap and pen in hand as she gazes off to the side with the pen resting on the side of her face as though she is thinking and contemplating while a glass of orange juice and a pair of red sunglasses rests on the table beside her.
Share Market News

Will these ASX 100 shares surge or sink in July?

These are two ASX favourites to watch closely this month. 

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Share Market News

3 ASX ETFs for smart investors

Let's see what makes these funds top picks for Aussie investors.

Read more »

A woman sits on sofa pondering a question.
Broker Notes

Guess which ASX All Ords media stock Macquarie expects to rise 17% over the next 12 months?

The broker is expecting big things from this media company.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Share Market News

5 things to watch on the ASX 200 on Thursday

It looks set to be a good session for Aussie investors on Thursday.

Read more »